Amrutanjan Health Care Limited Stock NSE India S.E.

Equities

AMRUTANJAN

INE098F01023

Pharmaceuticals

Delayed NSE India S.E. 07:27:49 2021-10-05 am EDT 5-day change 1st Jan Change
828 INR +0.12% Intraday chart for Amrutanjan Health Care Limited -1.46% +64.69%
Sales 2022 4.06B 48.69M Sales 2023 3.8B 45.55M Capitalization 16.81B 202M
Net income 2022 672M 8.06M Net income 2023 398M 4.77M EV / Sales 2022 5.22 x
Net cash position 2022 2B 24.01M Net cash position 2023 1.89B 22.66M EV / Sales 2023 3.93 x
P/E ratio 2022
34.5 x
P/E ratio 2023
42.2 x
Employees -
Yield 2022
0.58%
Yield 2023
0.8%
Free-Float 45.17%
More Fundamentals * Assessed data
Dynamic Chart
Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2023-24 CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2023-2024 CI
Amrutanjan Health Care Limited Declares Final Dividend for the Year Ended March 31, 2023 CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023. CI
Amrutanjan Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023. CI
Amrutanjan Health Care Limited's Equity Buyback announced on June 30, 2023, has closed with 320,000 shares, representing 1.09% for INR 288 million. CI
Amrutanjan Health Care Gets Board's Nod to Buy Back Up to INR288 Million Worth of Shares; Shares Surge 12% MT
Amrutanjan Health Care Limited Announces Board Changes CI
Amrutanjan Health Care Limited announces an Equity Buyback for 320,000 shares, representing 1.09% for INR 288 million. CI
Amrutanjan Health Care Limited authorizes a Buyback Plan. CI
Amrutanjan Health Care Limited’s Board intends to launch an Equity Buyback on June 30, 2023. CI
More news
Managers TitleAgeSince
Chief Executive Officer 49 99-01-21
Director of Finance/CFO - 17-11-08
Chief Tech/Sci/R&D Officer - 20-03-31
Members of the board TitleAgeSince
Chief Executive Officer 49 99-01-21
Director/Board Member 67 15-05-14
Director/Board Member - 22-08-11
More insiders
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene. Its segments include OTC Products, Beverages, and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. The Company’s beverages include Fruitnik and Fruitnik Electro+.
More about the company